Yonghe Medical Group Co (STU:L97) Marketable Securities: €18.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:L97 Yonghe Medical Group Co Ltd STU:L97
84 GF Score
Price €0.26
GF Value €0.20
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co Marketable Securities?

Yonghe Medical Group Co STU:L97 +2.38% 84 Marketable Securities is €18.0 Mil as of Jun. 2026. GuruFocus rates STU:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.20. The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Yonghe Medical Group Co's Marketable Securities for the quarter that ended in Jun. 2026 was €18.0 Mil.

Yonghe Medical Group Co's annual Marketable Securities stayed the same from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€6.1 Mil).

Yonghe Medical Group Co  (STU:L97) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Yonghe Medical Group Co Marketable Securities Related Terms

Yonghe Medical Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co Marketable Securities Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 55.91 0.00 0.00 6.09

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 6.09 17.98
STU:L97
84GF Score
Yonghe Medical Group Co Ltd STU:L97
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €18.0 Mil mean?
Yonghe Medical Group Co (STU:L97) has a Marketable Securities of €18.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Yonghe Medical Group Co and its competitors.
Is Yonghe Medical Group Co's Marketable Securities too high?
Yonghe Medical Group Co's current Marketable Securities is €18.0 Mil. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Marketable Securities compare to HCA and THC?
Yonghe Medical Group Co's Marketable Securities of €18.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Yonghe Medical Group Co and its competitors. Yonghe Medical Group Co's current Marketable Securities is €18.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (STU:L97) has a current Marketable Securities of €18.0 Mil. The stock's GF Value™ is €0.20, compared to a current price of €0.26 — trading 29% above its estimated fair value. The current Marketable Securities is €18.0 Mil. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Yonghe Medical Group Co (STU:L97), the current Marketable Securities is €18.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (STU:L97) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of €0.26 is trading 29% above its estimated GF Value™ of €0.20.

Key valuation signals for STU:L97:

  • Marketable Securities: €18.0 Mil
  • GF Value™: €0.20 vs. price of €0.26 (29% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the STU:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yonghe Medical Group Co Business Description

Other Exchanges 02279:Hong KongL97:Germany
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for STU:L97

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.20
GF Value